Archives of Gerontology and Geriatrics, Journal Year: 2024, Volume and Issue: 129, P. 105686 - 105686
Published: Nov. 6, 2024
Language: Английский
Archives of Gerontology and Geriatrics, Journal Year: 2024, Volume and Issue: 129, P. 105686 - 105686
Published: Nov. 6, 2024
Language: Английский
Current Opinion in Endocrinology Diabetes and Obesity, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 28, 2024
Purpose of review The aim this article was to the up-to-date evidence with regards unique features Type 2 diabetes (T2D) pathophysiology, complications, response therapy possibility precision medicine guiding therapeutic decision making in Asia. Recent findings Asia is epicenter diabetes. There have been marked advances genotyping and phenotyping Asian patient T2D, particularly young onset where early beta cell failure rapid progression complications are more frequent. As Asians lower muscle mass higher adiposity, sarcopenia increasingly associated Response lifestyle pharmacotherapy generally similar, but exist different populations. Across Asia, use guideline directed medical for cardio-renal protection recommended, uptake these newer agents suboptimal barriers standardized care. Summary Although many similarities observed across due heterogeneity populations within further research required streamline pave way towards medicine. an urgent need region wide consensus minimize care stigma terminology
Language: Английский
Citations
1Archives of Gerontology and Geriatrics, Journal Year: 2024, Volume and Issue: 129, P. 105686 - 105686
Published: Nov. 6, 2024
Language: Английский
Citations
0